Table 1.
IGRA+ group |
IGRA- Healthy control group |
||
---|---|---|---|
Number | 18 | 4 | |
Age in years: Median (IQR) | 34 (28–38) | 28 (27–29) | |
Gender | Male | 10 (56%) | 3 (75%) |
Female | 8 (44%) | 1 (25%) | |
Confirmed recent drug-susceptible TB exposure | Yes | 15 (83%) | 0 (0%) |
No | 3 (17%) | 4 (100%) | |
BCG | Yes | 14 (78%) | 2 (50%) |
No | 2 (11%) | 2 (50%) | |
Unknown | 2 (11%) | 0 (0%) | |
Continent of Birth | Africa | 4 (22%) | 0 (0%) |
Asia | 4 (22%) | 0 (0%) | |
Australasia | 0 (0%) | 1 (25%) | |
Europe | 9 (50%) | 2 (50%) | |
North America | 0 (0%) | 1 (25%) | |
South America | 1 (6%) | 0 (0%) | |
Unknown | 0 (0%) | 0 (0%) | |
Ethnicity | Asiana | 5 (28%) | 2 (50%) |
Blackb | 4 (22%) | 0 (0%) | |
Whitec | 8 (44%) | 2 (50%) | |
Otherd | 1 (6%) | 0 (0%) |
Includes Bengali, Hong Kong, Kurdish, Sri Lankan, Turkish.
Includes Black African.
Includes White British, Polish, Romanian, White other.
Includes Latin American, Unknown.